Starbloom Capital logo

Starbloom Capital

North America, Texas, United States, Houston

Description

Starbloom Capital is a early-stage venture capital fund.

Investor Profile

Starbloom Capital has made 8 investments, with 1 in the past 12 months and 25% as lead.

Stage Focus

  • Seed (50%)
  • Series B (13%)
  • Pre Seed (13%)
  • Series Unknown (13%)
  • Series A (13%)

Country Focus

  • United States (75%)
  • United Kingdom (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Life Science
  • Pharmaceutical
  • Therapeutics
  • Oncology
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Starbloom Capital frequently co-invest with?

PF
North America, Illinois, United States, Deerfield
Co-Investments: 1
IAG Capital Partners
North America, South Carolina, United States, Charleston
Co-Investments: 1
Pebblebed
North America, California, United States, San Francisco
Co-Investments: 1
Day One Ventures
North America, California, United States, San Francisco
Co-Investments: 1
FoundersX Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Morningside Venture Investments
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Alzheimer's Drug Discovery Foundation
North America, New York, United States, New York
Co-Investments: 1
WI
North America, California, United States, San Francisco
Co-Investments: 1
KIZOO Technology Capital
Europe, Baden-Wurttemberg, Germany, Karlsruhe
Co-Investments: 2
CC
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Starbloom Capital often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
FS
North America, California, United States, Palo Alto
Shared Deals: 1
DF
North America, California, United States, Penngrove
Shared Deals: 1
BA
North America, California, United States, San Francisco
Shared Deals: 1
AM
North America, California, United States, San Francisco
Shared Deals: 1
MS
North America, New York, United States, New York
Shared Deals: 1
AW
North America, California, United States, San Francisco
Shared Deals: 1
GC
North America, Massachusetts, United States, Boston
Shared Deals: 1
EG
North America, California, United States, San Francisco
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Starbloom Capital?

LIfT BioSciences

London, England, United Kingdom

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

BiopharmaBiotechnologyHealth CareLife ScienceMedicalOncologyPharmaceutical
Series ASep 24, 2024
Amount Raised: $13,426,856
Orchid

San Francisco, California, United States

Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.

BiotechnologyHealth CareMedicalmHealth
SeedDec 5, 2023
Amount Raised: $12,000,000
Cognito Therapeutics

Cambridge, Massachusetts, United States

Cognito Therapeutics is a neurotechnology company that is developing disease-modifying treatments for CNS illnesses.

BiotechnologyHealth CareHealth DiagnosticsMedical DeviceTherapeutics
Series BMar 22, 2023
Amount Raised: $73,000,000
TBD Health

New York, New York, United States

TBD Health makes at-home STD/STI screening kits that are accurate, easy to use, and built for women.

FitnessHealth CareWellness
SeedJan 31, 2023
Amount Raised: $4,400,000
Rysk Finance

San Francisco, California, United States

Rysk Finance is a derivatives decentralized market maker.

Decentralized Finance (DeFi)FinanceFinTech
Pre SeedJan 31, 2023
Amount Raised: $1,400,000
LIfT BioSciences

London, England, United Kingdom

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

BiopharmaBiotechnologyHealth CareLife ScienceMedicalOncologyPharmaceutical
Series UnknownDec 19, 2022
Elastrin Therapeutics

Simpsonville, South Carolina, United States

Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.

BiopharmaBiotechnologyTherapeutics
SeedApr 7, 2022
Amount Raised: $10,000,000
Revel Pharmaceuticals

San Francisco, California, United States

Revel Pharmaceuticals develops therapeutics for multiple diseases of aging including osteoarthritis, kidney, and complications of diabetes.

BiotechnologyLife SciencePharmaceutical
SeedMar 17, 2022
Amount Raised: $8,400,000